The present invention relates to a compound for inhibiting thymic stromal lymphopoietin (TSLP) secretion from mast cells and use thereof. The compound of the present invention was confirmed to significantly inhibit TSLP secretion from mast cells and, accordingly, may be used as a candidate compound for treating and preventing atopic dermatitis, allergic dermatitis, and/or inflammatory bowel disease.
